Health news round-up: new cancer drugs, pharmacogenomics, and whether GLP-1s cause erectile dysfunction Our weekly summary of the important developments in pharmacy and health news you may have missed.…
Paxlovid speeds COVID-19 recovery but does not reduce hospital admissions Across two trials, more than 4,000 patients were randomised to receive usual care or Paxlovid (nirmatrelvir and ritonavir; Pfizer) within three or four days of symptom onset.…
Pharmacies deliver almost 16,000 RSV vaccinations as programme found to cut newborn hospitalisations by up to 85% Babies born at least four weeks after their mother received a respiratory syncytial virus vaccination had nearly 85% protection against the virus.…
Health news round-up: semaglutide and liver health, obesity vaccine response and hope for pancreatic cancer Our weekly summary of the important developments in pharmacy and health news you may have missed.…
Recognition and management of whooping cough As the number of whooping cough cases rise, this article outlines the role of pharmacy in recognising and managing the condition.…
News round-up: long COVID, chikungunya and free supplies of ciprofloxacin Our weekly summary of the important developments in pharmacy and health news you may have missed.…
Everything you need to know about meningitis B Facts about meningitis transmission, its warning signs and vaccine effectiveness, including a summary of what we know about the outbreak in Kent.…
COVID-19 vaccines not associated with sudden death in healthy young people The researchers found no significant difference between the first, second and third dose of the COVID-19 vaccine in terms of increased risk of sudden cardiac death in healthy young patients.…
Health news round-up: antidepressants, hospital admissions and rheumatology workforce A weekly summary of important developments in pharmacy and health news that you may have missed.…
Pharmacies administered more than 10% of all vaccines in RSV pilot The NHS pilot was aimed to test the potential for community pharmacies to increase equity in access to the respiratory syncytial virus vaccine.…
